June 25-26, 2020

3rd Annual MarketsandMarkets Next-Gen Immuno-Oncology Congress - VIRTUAL EVENT

45+
Speakers
200+
Attendees
10
Networking Hours
10+
Sessions

Due to growing concerns about COVID-19, the 3rd Annual MarketsandMarkets Next Gen IO Congress is going fully virtual this year. We are disappointed that we are not able to come together in person in June for this event, but we are so thrilled to see you on an online platform. We are working together to create a virtual conference that will be beneficial and engaging for speakers, attendees and sponsors/exhibitors.

See the Post Show report of our 2nd Annual here

Please write to event@marketsandmarket.com for questions regarding speaking, attending and sponsoring. We will keep you posted with the event flow soon. Keep checking our website.

WHAT TO EXPECT
Key Highlights
  • Immune Checkpoint Inhibitors and Combinations
  • Preclinical and Translational Immuno-Oncology Developments (Preclinical models for Immune checkpoint modulators)
  • Monoclonal Antibody & Cellular Therapy
  • Neoantigens in personalized Cancer Immunotherapy
  • Biomarkers and Cancer Vaccines
  • Developments in CAR-T Cellular Therapy
  • Oncolytic Viral Therapy & Personalized Medicine
  • Engineering Cellular Therapies Beyond Traditional Tumor Antigens
  • Combination Therapies in I/O
Why attend Virtual?
  • Exclusive Virtual event to learn about antibodies, cellular therapy and immune-checkpoint research under one roof
  • Find out new case studies of immune-oncology projects in development
  • Contribute to interactive Q&A sessions with your peers to deliberate key topics most relevant to you
  • Explore the latest platforms and technologies on the market for development
  • Discuss the best tool for your research in immune-oncology
CONFERENCE SPEAKERS
Advisors
Rakesh Dixit

Rakesh Dixit

CEO
Bionavigen

Rakesh Dixit

CEO
Bionavigen
Roy Baynes

Roy Baynes

Senior Vice President
Merck

Roy Baynes

Senior Vice President
Merck
Darrell Borger

Darrell Borger

Associate Director, Translational Sciences, ODDU
Takeda

Darrell Borger

Associate Director, Translational Sciences, ODDU
Takeda
Mithun Khattar

Mithun Khattar

Immuno-Oncology Lead
Takeda Oncology

Mithun Khattar

Immuno-Oncology Lead
Takeda Oncology
Speakers
Shailendra Singh (Shelly)

Shailendra Singh (Shelly)

Chief Operating Officer
MarketsandMarkets

Shailendra Singh (Shelly)

Chief Operating Officer
MarketsandMarkets
Rakesh Dixit

Rakesh Dixit

CEO
Bionavigen

Rakesh Dixit

CEO
Bionavigen
Roy Baynes

Roy Baynes

Senior Vice President
Merck

Roy Baynes

Senior Vice President
Merck
Stefan Gluck

Stefan Gluck

Vice President
Celgene, USA

Stefan Gluck

Vice President
Celgene, USA
Dave Wustrow

Dave Wustrow

Senior VP Discovery and Preclinical Development
RAPT Therapeutics

Dave Wustrow

Senior VP Discovery and Preclinical Development
RAPT Therapeutics
Darrell Borger

Darrell Borger

Associate Director, Translational Sciences, ODDU
Takeda

Darrell Borger

Associate Director, Translational Sciences, ODDU
Takeda
Robert Petit

Robert Petit

Chief Scientific Officer
Carisma Therapeutics

Robert Petit

Chief Scientific Officer
Carisma Therapeutics
Nuzhat Pathan

Nuzhat Pathan

Director, Early Development, Translational and Immuno-Oncology
Pfizer

Nuzhat Pathan

Director, Early Development, Translational and Immuno-Oncology
Pfizer
SPONSORS
Gold
example-image

BIOCYTOGEN

example-image

Applied BioMath

Sponsors & Exhibitors
example-image

PromoCell

example-image

TransCure bioServices

example-image

BerGenBio

example-image

Imaging Endpoints

example-image

Q2 Solutions

example-image

CellGenix

example-image

Thermo Fisher Scientific

PAST EVENT GALLERY